340B Drug Pricing Program
The House Energy and Commerce Committee yesterday released a report on the 340B Drug Pricing Program. “The 340B program is an important program that enjoys strong bipartisan support in Congress,” the report says.
I hereby certify that on this 9th day of January, 2018, I electronically filed the foregoing NOTICE OF APPEAL by using the CM/ECF system. All parties to the case have been served through the CM/ECF system.
The American Hospital Association, the Association of American Medical Colleges and America's Essential Hospitals today formally notified the court of their intent to appeal the district court’s Dec. 29 decision dismissing the groups’ lawsuit that sought to prevent Medicare payment cuts for many…
It’s a new year but Congress has some old business to attend to—including many critical hospital and health system priorities. Both Houses of Congress will be back in session next week. Front and center is legislation to keep the government open past January 19.
Granting defendants’ motion to dismiss; denying as moot plaintiffs’ motion for a preliminary injunction; and denying motion for leave to file brief as amici curiae.
District Court Judge Rudolph Contreras today heard arguments from both sides in the AHA's lawsuit to prevent the Department of Health and Human Services from reducing Medicare payments under the 340B drug savings program by nearly 30% effective Jan. 1.